Ed Conway on Living in the Material World
The economics journalist talks about his travels to see how the substances we need for modern life are extracted and produced, the trade-offs involved and...
Showing 421 - 432 of 1686
The China Risk in Index Funds
A look into how funds that track major indexes could be investing in companies with controversial links in China.
The WuXi Way
WuXi AppTec is the most important drugmaker American patients have never heard of.
Could Kamala Harris Be the Next Richard Nixon?
The looming superpower clash between the United States and China begs for another strategic breakthrough.
WuXi Waylaid
When Congress resumes next month, the BioSecure Act will be one of its top priorities. The bill, which could dramatically reorder the global pharmaceutical supply...
David Zweig on the Academic Chill Between the U.S. and China
The social scientist and author discusses the fallout from the Trump administration’s China Initiative and how the U.S. should approach academic links with its strategic...
China’s Chip Consolidation
Beijing is weeding out bad actors in the semiconductor industry and concentrating its resources on well-established firms.
Clean Tech 2.0
Can the U.S. leapfrog China on green tech?
Who’s Who in the Rare Earth Industry
China has a virtual monopoly over midstream processing of rare earths.
The Green Leap
From solar panels to electric vehicles, China dominates several of the technologies needed for the green energy transition. But can the U.S. find a way...
China Must Rein in Local Governments
The decentralization of decision-making was essential to China’s economic boom in its early years, but further economic reform will require the central government to reassert...
Walz’s China Chops
A look at Tim Walz's China background.